Fundraising Fox

Cambridge Technologies

Worthington, US · Minnesota LLC

cambridgetechnologies.com ↗

Cambridge Technologies provides veterinarians with next-generation diagnostics and custom-manufactured autogenous vaccines for production animals, including beef and dairy cattle, swine, and small ruminants. Using its "Precision Vaccinology" process, the company sequences herd samples to identify pathogens and formulates herd-specific vaccines to prevent disease and reduce antibiotic dependence.

AgTechBiotechHealthtech

Founders & leadership

WF
Wayne FreeseVice President and Governor
RSRandy Simonson
Randy SimonsonChief Executive Officer and Governor
DT
Donna TimsTreasurer, Secretary, and Governor

Board

CF
Carl Frank StonerGovernor
MF
Marc FreeseGovernor
JD
James Douglas RasmussenGovernor
RL
Reed LeitingGovernor

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 1 round · 2018

▶$3.5MraisedJan 2018 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Wayne FreeseExecutive Officer, Director
  • Carl Frank StonerDirector
  • Randy SimonsonExecutive Officer, Director
  • Marc FreeseDirector
  • Donna TimsExecutive Officer, Director
  • James Douglas RasmussenDirector
  • Reed LeitingDirector
Offering amount
$3.5M
Amount sold
$3.5M
Minimum investment
$3.5M
First sale
Jan 2018
Incorporated
Limited Liability Company, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of Agriculture (USDA)Phase II2019$641.8K
Department of Agriculture (USDA)Phase I2018$100K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Cambridge Technologies do?
Cambridge Technologies provides veterinarians with next-generation diagnostics and custom-manufactured autogenous vaccines for production animals, including beef and dairy cattle, swine, and small ruminants. Using its "Precision Vaccinology" process, the company sequences herd samples to identify pathogens and formulates herd-specific vaccines to prevent disease and reduce antibiotic dependence.
How much funding has Cambridge Technologies raised?
Cambridge Technologies has disclosed $3.5M raised across 1 round.
Where is Cambridge Technologies headquartered?
Cambridge Technologies is headquartered in Worthington, US.